{"transactions":[{"id":4624107,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock Unit","published_at":"2026-09-18T20:39:13.000Z","date":"2026-09-16","kind":"exercise","planned":false,"acquired":false,"shares":7197,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"6.25% of the total award vested or vests quarterly, with the first tranche vested on June 16, 2023, subject to the Reporting Person's continued service to the Issuer on each vesting date. These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F9","text":"6.25% of the total award vested or vests quarterly, with the first tranche vested on June 16, 2023, subject to the Reporting Person's continued service to the Issuer on each vesting date. These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date."}],"balance_after":14393,"derivative":{"underlying":"Class A Common Stock","underlying_shares":7197},"source":{"system":"sec-edgar","filing":"0001944119-26-000037","document":"form4-09182026_080909.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411926000037/form4-09182026_080909.xml","form_type":"4"}},{"id":4624106,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-09-18T20:39:13.000Z","date":"2026-09-16","kind":"sale","planned":false,"acquired":false,"shares":1079,"price":98.995,"value":106815.605,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $98.60 to $99.305 per share, inclusive."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F8","text":"Following the reported sale undertaken to satisfy tax withholding liabilities, in addition to the 44,945 shares of Class A Common Stock beneficially owned by the Reporting Person, the Reporting Person held RSUs representing contingent rights to receive up to an aggregate 71,667 shares of the Issuer's Class A Common Stock and options to purchase up to an aggregate 25,906 shares of Class A Common Stock, which RSUs and options vest according to their respective terms."}],"balance_after":44945,"source":{"system":"sec-edgar","filing":"0001944119-26-000037","document":"form4-09182026_080909.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411926000037/form4-09182026_080909.xml","form_type":"4"}},{"id":4624105,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-09-18T20:39:13.000Z","date":"2026-09-16","kind":"sale","planned":false,"acquired":false,"shares":1470,"price":98.27,"value":144456.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $97.565 to $98.535 per share, inclusive."}],"balance_after":46024,"source":{"system":"sec-edgar","filing":"0001944119-26-000037","document":"form4-09182026_080909.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411926000037/form4-09182026_080909.xml","form_type":"4"}},{"id":4624104,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-09-18T20:39:13.000Z","date":"2026-09-16","kind":"sale","planned":false,"acquired":false,"shares":541,"price":96.9009,"value":52423.3869,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.445 to $97.40 per share, inclusive."}],"balance_after":47494,"source":{"system":"sec-edgar","filing":"0001944119-26-000037","document":"form4-09182026_080909.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411926000037/form4-09182026_080909.xml","form_type":"4"}},{"id":4624103,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-09-18T20:39:13.000Z","date":"2026-09-16","kind":"sale","planned":false,"acquired":false,"shares":52,"price":95.405,"value":4961.06,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.29 to $95.52 per share, inclusive."}],"balance_after":48035,"source":{"system":"sec-edgar","filing":"0001944119-26-000037","document":"form4-09182026_080909.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411926000037/form4-09182026_080909.xml","form_type":"4"}},{"id":4624102,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-09-18T20:39:13.000Z","date":"2026-09-16","kind":"sale","planned":false,"acquired":false,"shares":586,"price":94.258,"value":55235.188,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.23 to $94.855 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnotes 4 through 7 of this Form 4."}],"balance_after":48087,"source":{"system":"sec-edgar","filing":"0001944119-26-000037","document":"form4-09182026_080909.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411926000037/form4-09182026_080909.xml","form_type":"4"}},{"id":4624101,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-09-18T20:39:13.000Z","date":"2026-09-16","kind":"exercise","planned":false,"acquired":true,"shares":7197,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."}],"balance_after":48673,"source":{"system":"sec-edgar","filing":"0001944119-26-000037","document":"form4-09182026_080909.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411926000037/form4-09182026_080909.xml","form_type":"4"}},{"id":4615845,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock Unit","published_at":"2026-09-11T20:10:55.000Z","date":"2026-09-09","kind":"exercise","planned":false,"acquired":false,"shares":2462,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"6.25% of the total award vested or vests quarterly, subject to the Reporting Person's continued service to the Issuer on each vesting date, and with the first tranche vested on March 9, 2023. These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"6.25% of the total award vested or vests quarterly, subject to the Reporting Person's continued service to the Issuer on each vesting date, and with the first tranche vested on March 9, 2023. These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date."}],"balance_after":2463,"derivative":{"underlying":"Class A Common Stock","underlying_shares":2462},"source":{"system":"sec-edgar","filing":"0001944119-26-000035","document":"form4-09112026_080950.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411926000035/form4-09112026_080950.xml","form_type":"4"}},{"id":4615844,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-09-11T20:10:55.000Z","date":"2026-09-09","kind":"sale","planned":false,"acquired":false,"shares":1285,"price":84.2179,"value":108220.0015,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.08 to $84.22 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Following the reported sale undertaken to satisfy tax withholding liabilities, in addition to the 41,476 shares of Class A Common Stock beneficially owned by the Reporting Person, the Reporting Person held RSUs representing contingent rights to receive up to an aggregate of 78,864 shares of Class A Common Stock and options to purchase up to an aggregate of 25,906 shares of Class A Common Stock, which RSUs and options vest according to their respective terms."}],"balance_after":41476,"source":{"system":"sec-edgar","filing":"0001944119-26-000035","document":"form4-09112026_080950.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411926000035/form4-09112026_080950.xml","form_type":"4"}},{"id":4615843,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-09-11T20:10:55.000Z","date":"2026-09-09","kind":"exercise","planned":false,"acquired":true,"shares":2462,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."}],"balance_after":42761,"source":{"system":"sec-edgar","filing":"0001944119-26-000035","document":"form4-09112026_080950.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411926000035/form4-09112026_080950.xml","form_type":"4"}},{"id":2075,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock Unit","published_at":"2026-09-03T20:09:28.000Z","date":"2026-09-01","kind":"exercise","planned":false,"acquired":false,"shares":717,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"6.25% of the total award vested or vests quarterly, with the first tranche vested on December 1, 2022, subject to the Reporting Person's continued service to the Issuer on each vesting date. These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"6.25% of the total award vested or vests quarterly, with the first tranche vested on December 1, 2022, subject to the Reporting Person's continued service to the Issuer on each vesting date. These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":717},"source":{"system":"sec-edgar","filing":"0001944119-26-000033","document":"form4-09032026_080923.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411926000033/form4-09032026_080923.xml","form_type":"4"}},{"id":2074,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-09-03T20:09:28.000Z","date":"2026-09-01","kind":"sale","planned":false,"acquired":false,"shares":372,"price":83.839,"value":31188.108,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.71 to $83.84 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Following the reported sale undertaken to satisfy tax withholding liabilities, in addition to the 40,299 shares of Class A Common Stock beneficially owned by the Reporting Person, the Reporting Person held RSUs representing contingent rights to receive up to an aggregate 81,326 shares of the Issuer's Class A Common Stock and options to purchase up to an aggregate 25,906 shares of Class A Common Stock, which RSUs and options vest according to their respective terms."}],"balance_after":40299,"source":{"system":"sec-edgar","filing":"0001944119-26-000033","document":"form4-09032026_080923.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411926000033/form4-09032026_080923.xml","form_type":"4"}},{"id":2073,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-09-03T20:09:28.000Z","date":"2026-09-01","kind":"exercise","planned":false,"acquired":true,"shares":717,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."}],"balance_after":40671,"source":{"system":"sec-edgar","filing":"0001944119-26-000033","document":"form4-09032026_080923.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411926000033/form4-09032026_080923.xml","form_type":"4"}},{"id":732356,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock Unit","published_at":"2026-06-18T20:11:25.000Z","date":"2026-06-16","kind":"exercise","planned":false,"acquired":false,"shares":7197,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"6.25% of the total award vested or vests quarterly, with the first tranche vested on June 16, 2023, subject to the Reporting Person's continued service to the Issuer on each vesting date. These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"6.25% of the total award vested or vests quarterly, with the first tranche vested on June 16, 2023, subject to the Reporting Person's continued service to the Issuer on each vesting date. These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date."}],"balance_after":21590,"derivative":{"underlying":"Class A Common Stock","underlying_shares":7197},"source":{"system":"sec-edgar","filing":"0001944119-26-000031","document":"form4-06182026_080621.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411926000031/form4-06182026_080621.xml","form_type":"4"}},{"id":732355,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-06-18T20:11:25.000Z","date":"2026-06-16","kind":"sale","planned":false,"acquired":false,"shares":863,"price":61.5035,"value":53077.5205,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.44 to $61.69 per share, inclusive."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Following the reported sale undertaken to satisfy tax withholding liabilities, in addition to the 39,954 shares of Class A Common Stock beneficially owned by the Reporting Person, the Reporting Person held RSUs representing contingent rights to receive up to an aggregate 82,043 shares of the Issuer's Class A Common Stock and options to purchase up to an aggregate 25,906 shares of Class A Common Stock, which RSUs and options vest according to their respective terms."}],"balance_after":39954,"source":{"system":"sec-edgar","filing":"0001944119-26-000031","document":"form4-06182026_080621.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411926000031/form4-06182026_080621.xml","form_type":"4"}},{"id":732354,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-06-18T20:11:25.000Z","date":"2026-06-16","kind":"sale","planned":false,"acquired":false,"shares":2106,"price":60.8291,"value":128106.0846,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.40 to $61.35 per share, inclusive."}],"balance_after":40817,"source":{"system":"sec-edgar","filing":"0001944119-26-000031","document":"form4-06182026_080621.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411926000031/form4-06182026_080621.xml","form_type":"4"}},{"id":732353,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-06-18T20:11:25.000Z","date":"2026-06-16","kind":"sale","planned":false,"acquired":false,"shares":760,"price":59.7543,"value":45413.268,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.26 to $60.24 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnotes 4 and 5 of this Form 4."}],"balance_after":42923,"source":{"system":"sec-edgar","filing":"0001944119-26-000031","document":"form4-06182026_080621.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411926000031/form4-06182026_080621.xml","form_type":"4"}},{"id":732352,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-06-18T20:11:25.000Z","date":"2026-06-16","kind":"exercise","planned":false,"acquired":true,"shares":7197,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."}],"balance_after":43683,"source":{"system":"sec-edgar","filing":"0001944119-26-000031","document":"form4-06182026_080621.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411926000031/form4-06182026_080621.xml","form_type":"4"}},{"id":741951,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock Unit","published_at":"2026-06-11T20:12:45.000Z","date":"2026-06-09","kind":"exercise","planned":false,"acquired":false,"shares":2462,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"6.25% of the total award vested or vests quarterly, subject to the Reporting Person's continued service to the Issuer on each vesting date, and with the first tranche vested on March 9, 2023. These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"6.25% of the total award vested or vests quarterly, subject to the Reporting Person's continued service to the Issuer on each vesting date, and with the first tranche vested on March 9, 2023. These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date."}],"balance_after":4925,"derivative":{"underlying":"Class A Common Stock","underlying_shares":2462},"source":{"system":"sec-edgar","filing":"0001944119-26-000029","document":"form4-06112026_080641.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411926000029/form4-06112026_080641.xml","form_type":"4"}},{"id":741950,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-06-11T20:12:45.000Z","date":"2026-06-09","kind":"sale","planned":false,"acquired":false,"shares":1266,"price":53.77,"value":68072.82,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Following the reported sale undertaken to satisfy tax withholding liabilities, in addition to the 36,486 shares of Class A Common Stock beneficially owned by the Reporting Person, the Reporting Person beneficially owned RSUs representing contingent rights to receive up to an aggregate of 89,240 shares of Class A Common Stock and options to purchase up to an aggregate of 25,906 shares of Class A Common Stock, which RSUs and options vest according to their respective terms."}],"balance_after":36486,"source":{"system":"sec-edgar","filing":"0001944119-26-000029","document":"form4-06112026_080641.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411926000029/form4-06112026_080641.xml","form_type":"4"}},{"id":741949,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-06-11T20:12:45.000Z","date":"2026-06-09","kind":"exercise","planned":false,"acquired":true,"shares":2462,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."}],"balance_after":37752,"source":{"system":"sec-edgar","filing":"0001944119-26-000029","document":"form4-06112026_080641.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411926000029/form4-06112026_080641.xml","form_type":"4"}},{"id":752193,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock Unit","published_at":"2026-06-03T20:16:45.000Z","date":"2026-06-01","kind":"exercise","planned":false,"acquired":false,"shares":717,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"6.25% of the total award vested or vests quarterly, subject to the Reporting Person's continued service to the Issuer on each vesting date, and with the first tranche vested on December 1, 2022. These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"6.25% of the total award vested or vests quarterly, subject to the Reporting Person's continued service to the Issuer on each vesting date, and with the first tranche vested on December 1, 2022. These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date."}],"balance_after":717,"derivative":{"underlying":"Class A Common Stock","underlying_shares":717},"source":{"system":"sec-edgar","filing":"0001944119-26-000027","document":"form4-06032026_080638.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411926000027/form4-06032026_080638.xml","form_type":"4"}},{"id":752192,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-06-03T20:16:45.000Z","date":"2026-06-01","kind":"sale","planned":false,"acquired":false,"shares":369,"price":51.74,"value":19092.06,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Following the reported sale undertaken to satisfy tax withholding liabilities, in addition to the 35,290 shares of Class A Common Stock beneficially owned by the Reporting Person, the Reporting Person beneficially owned RSUs representing contingent rights to receive up to an aggregate 91,702 shares of Class A Common Stock and options to purchase up to an aggregate 25,906 shares of Class A Common Stock, which RSUs and options vest according to their respective terms."}],"balance_after":35290,"source":{"system":"sec-edgar","filing":"0001944119-26-000027","document":"form4-06032026_080638.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411926000027/form4-06032026_080638.xml","form_type":"4"}},{"id":752191,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-06-03T20:16:45.000Z","date":"2026-06-01","kind":"exercise","planned":false,"acquired":true,"shares":717,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."}],"balance_after":35659,"source":{"system":"sec-edgar","filing":"0001944119-26-000027","document":"form4-06032026_080638.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411926000027/form4-06032026_080638.xml","form_type":"4"}},{"id":795853,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock Unit","published_at":"2026-05-01T20:24:33.000Z","date":"2026-04-29","kind":"exercise","planned":false,"acquired":false,"shares":754,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"25% of the total award vested on each of April 29, 2023 and April 29, 2024, and an additional 6.25% of the total award vested or vests thereafter on each quarterly anniversary, subject to the Reporting Person's continued service to the Issuer on each vesting date, with the last tranche vesting on April 29, 2026.  These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"25% of the total award vested on each of April 29, 2023 and April 29, 2024, and an additional 6.25% of the total award vested or vests thereafter on each quarterly anniversary, subject to the Reporting Person's continued service to the Issuer on each vesting date, with the last tranche vesting on April 29, 2026.  These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":754},"source":{"system":"sec-edgar","filing":"0001944119-26-000024","document":"form4-05012026_080528.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411926000024/form4-05012026_080528.xml","form_type":"4"}},{"id":795852,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-05-01T20:24:33.000Z","date":"2026-04-29","kind":"sale","planned":false,"acquired":false,"shares":392,"price":65.1926,"value":25555.4992,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.4739 to $65.20 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Following the reported sale undertaken to satisfy tax withholding liabilities, in addition to the 34,942 shares of Class A Common Stock beneficially owned by the Reporting Person, the Reporting Person beneficially owned RSUs representing contingent rights to receive up to an aggregate of 92,419 shares of Class A Common Stock and options to purchase up to an aggregate of 25,906 shares of Class A Common Stock, which RSUs and options vest according to their respective terms."}],"balance_after":34942,"source":{"system":"sec-edgar","filing":"0001944119-26-000024","document":"form4-05012026_080528.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411926000024/form4-05012026_080528.xml","form_type":"4"}},{"id":795851,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-05-01T20:24:33.000Z","date":"2026-04-29","kind":"exercise","planned":false,"acquired":true,"shares":754,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."}],"balance_after":35334,"source":{"system":"sec-edgar","filing":"0001944119-26-000024","document":"form4-05012026_080528.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411926000024/form4-05012026_080528.xml","form_type":"4"}},{"id":825383,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock Unit","published_at":"2026-03-30T21:38:19.000Z","date":"2026-03-26","kind":"exercise","planned":false,"acquired":false,"shares":16250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"25% of the total award vested or vests annually, with the first tranche vested on March 26, 2025, subject to the Reporting Person's continued service to the Issuer on each vesting date. These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F9","text":"25% of the total award vested or vests annually, with the first tranche vested on March 26, 2025, subject to the Reporting Person's continued service to the Issuer on each vesting date. These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date."}],"balance_after":32500,"derivative":{"underlying":"Class A Common Stock","underlying_shares":16250},"source":{"system":"sec-edgar","filing":"0001944119-26-000021","document":"form4-03302026_090356.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411926000021/form4-03302026_090356.xml","form_type":"4"}},{"id":825382,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-03-30T21:38:19.000Z","date":"2026-03-26","kind":"sale","planned":false,"acquired":false,"shares":1857,"price":65.2143,"value":121102.9551,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.00 to $65.61 per share, inclusive."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F8","text":"Following the reported sale undertaken to satisfy tax withholding liabilities, in addition to the 34,580 shares of Class A Common Stock beneficially owned by the Reporting Person, the Reporting Person held RSUs representing contingent rights to receive up to an aggregate 93,173 shares of the Issuer's Class A Common Stock and options to purchase up to an aggregate 25,906 shares of Class A Common Stock, which RSUs and options vest according to their respective terms."}],"balance_after":34580,"source":{"system":"sec-edgar","filing":"0001944119-26-000021","document":"form4-03302026_090356.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411926000021/form4-03302026_090356.xml","form_type":"4"}},{"id":825381,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-03-30T21:38:19.000Z","date":"2026-03-26","kind":"sale","planned":false,"acquired":false,"shares":995,"price":64.5993,"value":64276.3035,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.99 to $64.96 per share, inclusive."}],"balance_after":36437,"source":{"system":"sec-edgar","filing":"0001944119-26-000021","document":"form4-03302026_090356.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411926000021/form4-03302026_090356.xml","form_type":"4"}},{"id":825380,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-03-30T21:38:19.000Z","date":"2026-03-26","kind":"sale","planned":false,"acquired":false,"shares":2520,"price":63.2791,"value":159463.332,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.96 to $63.955 per share, inclusive."}],"balance_after":37432,"source":{"system":"sec-edgar","filing":"0001944119-26-000021","document":"form4-03302026_090356.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411926000021/form4-03302026_090356.xml","form_type":"4"}},{"id":825379,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-03-30T21:38:19.000Z","date":"2026-03-26","kind":"sale","planned":false,"acquired":false,"shares":961,"price":62.3319,"value":59900.9559,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.93 to $62.91 per share, inclusive."}],"balance_after":39952,"source":{"system":"sec-edgar","filing":"0001944119-26-000021","document":"form4-03302026_090356.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411926000021/form4-03302026_090356.xml","form_type":"4"}},{"id":825378,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-03-30T21:38:19.000Z","date":"2026-03-26","kind":"sale","planned":false,"acquired":false,"shares":2485,"price":61.2909,"value":152307.8865,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.93 to $61.91 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnotes 4 through 7 of this Form 4."}],"balance_after":40913,"source":{"system":"sec-edgar","filing":"0001944119-26-000021","document":"form4-03302026_090356.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411926000021/form4-03302026_090356.xml","form_type":"4"}},{"id":825377,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-03-30T21:38:19.000Z","date":"2026-03-26","kind":"exercise","planned":false,"acquired":true,"shares":16250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."}],"balance_after":43398,"source":{"system":"sec-edgar","filing":"0001944119-26-000021","document":"form4-03302026_090356.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411926000021/form4-03302026_090356.xml","form_type":"4"}},{"id":838439,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock Unit","published_at":"2026-03-17T22:39:59.000Z","date":"2026-03-16","kind":"exercise","planned":false,"acquired":false,"shares":7197,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"6.25% of the total award vested or vests quarterly, with the first tranche vested on June 16, 2023, subject to the Reporting Person's continued service to the Issuer on each vesting date. These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"6.25% of the total award vested or vests quarterly, with the first tranche vested on June 16, 2023, subject to the Reporting Person's continued service to the Issuer on each vesting date. These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date."}],"balance_after":28787,"derivative":{"underlying":"Class A Common Stock","underlying_shares":7197},"source":{"system":"sec-edgar","filing":"0001944119-26-000019","document":"form4-03172026_100356.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411926000019/form4-03172026_100356.xml","form_type":"4"}},{"id":838438,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock Unit","published_at":"2026-03-17T22:39:59.000Z","date":"2026-03-15","kind":"exercise","planned":false,"acquired":false,"shares":3815,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"25% of the award vested or vests annually on the anniversary of the grant date, with the first tranche vested on March 15, 2026, subject to the Reporting Person's continued service to the Issuer on each vesting date.  These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"25% of the award vested or vests annually on the anniversary of the grant date, with the first tranche vested on March 15, 2026, subject to the Reporting Person's continued service to the Issuer on each vesting date.  These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date."}],"balance_after":11446,"derivative":{"underlying":"Class A Common Stock","underlying_shares":3815},"source":{"system":"sec-edgar","filing":"0001944119-26-000019","document":"form4-03172026_100356.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411926000019/form4-03172026_100356.xml","form_type":"4"}},{"id":838437,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-03-17T22:39:59.000Z","date":"2026-03-16","kind":"sale","planned":false,"acquired":false,"shares":257,"price":77.9354,"value":20029.3978,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.75 to $78.16 per share, inclusive."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Following the reported sale undertaken to satisfy tax withholding liabilities, in addition to the 27,148 shares of Class A Common Stock beneficially owned by the Reporting Person, the Reporting Person held RSUs representing contingent rights to receive up to an aggregate 109,423 shares of the Issuer's Class A Common Stock and options to purchase up to an aggregate 25,906 shares of Class A Common Stock, which RSUs and options vest according to their respective terms."}],"balance_after":27148,"source":{"system":"sec-edgar","filing":"0001944119-26-000019","document":"form4-03172026_100356.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411926000019/form4-03172026_100356.xml","form_type":"4"}},{"id":838436,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-03-17T22:39:59.000Z","date":"2026-03-16","kind":"sale","planned":false,"acquired":false,"shares":3065,"price":77.0495,"value":236156.7175,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $76.74 to $77.71 per share, inclusive."}],"balance_after":27405,"source":{"system":"sec-edgar","filing":"0001944119-26-000019","document":"form4-03172026_100356.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411926000019/form4-03172026_100356.xml","form_type":"4"}},{"id":838435,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-03-17T22:39:59.000Z","date":"2026-03-16","kind":"sale","planned":false,"acquired":false,"shares":2384,"price":76.3492,"value":182016.4928,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.735 to $76.73 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnotes 4 and 5 of this Form 4."}],"balance_after":30470,"source":{"system":"sec-edgar","filing":"0001944119-26-000019","document":"form4-03172026_100356.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411926000019/form4-03172026_100356.xml","form_type":"4"}},{"id":838434,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-03-17T22:39:59.000Z","date":"2026-03-16","kind":"exercise","planned":false,"acquired":true,"shares":7197,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."}],"balance_after":32854,"source":{"system":"sec-edgar","filing":"0001944119-26-000019","document":"form4-03172026_100356.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411926000019/form4-03172026_100356.xml","form_type":"4"}},{"id":838433,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-03-17T22:39:59.000Z","date":"2026-03-15","kind":"exercise","planned":false,"acquired":true,"shares":3815,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."}],"balance_after":25657,"source":{"system":"sec-edgar","filing":"0001944119-26-000019","document":"form4-03172026_100356.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411926000019/form4-03172026_100356.xml","form_type":"4"}},{"id":849018,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock Unit","published_at":"2026-03-11T20:28:48.000Z","date":"2026-03-09","kind":"exercise","planned":false,"acquired":false,"shares":2462,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"6.25% of the total award vested or vests quarterly, subject to the Reporting Person's continued service to the Issuer on each vesting date, and with the first tranche vested on March 9, 2023. These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"6.25% of the total award vested or vests quarterly, subject to the Reporting Person's continued service to the Issuer on each vesting date, and with the first tranche vested on March 9, 2023. These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date."}],"balance_after":7387,"derivative":{"underlying":"Class A Common Stock","underlying_shares":2462},"source":{"system":"sec-edgar","filing":"0001944119-26-000016","document":"form4-03112026_080344.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411926000016/form4-03112026_080344.xml","form_type":"4"}},{"id":849017,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-03-11T20:28:48.000Z","date":"2026-03-09","kind":"sale","planned":false,"acquired":false,"shares":1280,"price":86.754,"value":111045.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $86.75 to $87.1136 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Following the reported sale undertaken to satisfy tax withholding liabilities, in addition to the 21,842 shares of Class A Common Stock beneficially owned by the Reporting Person, the Reporting Person beneficially owned RSUs representing contingent rights to receive up to an aggregate of 120,435 shares of Class A Common Stock and options to purchase up to an aggregate of 25,906 shares of Class A Common Stock, which RSUs and options vest according to their respective terms."}],"balance_after":21842,"source":{"system":"sec-edgar","filing":"0001944119-26-000016","document":"form4-03112026_080344.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411926000016/form4-03112026_080344.xml","form_type":"4"}},{"id":849016,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-03-11T20:28:48.000Z","date":"2026-03-09","kind":"exercise","planned":false,"acquired":true,"shares":2462,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."}],"balance_after":23122,"source":{"system":"sec-edgar","filing":"0001944119-26-000016","document":"form4-03112026_080344.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411926000016/form4-03112026_080344.xml","form_type":"4"}},{"id":853812,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-03-09T11:56:01.000Z","date":"2026-03-06","kind":"grant","planned":false,"acquired":true,"shares":1986,"price":88.11,"value":174986.46,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Pursuant to a Subscription Agreement executed on March 6, 2026 between GeneDx Holdings Corp. (the \"Issuer\") and the reporting person, the reporting person acquired 1,986 shares of the Issuer's Class A common stock directly from the Issuer in an exempt transaction pursuant to Rule 16b-3(d) at a purchase price of $88.11 per share, the closing price of the Issuer's Class A common stock on March 6, 2026."}],"balance_after":20660,"source":{"system":"sec-edgar","filing":"0001944119-26-000014","document":"form4-03092026_110358.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411926000014/form4-03092026_110358.xml","form_type":"4"}},{"id":858881,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock Unit","published_at":"2026-03-05T22:49:11.000Z","date":"2026-03-03","kind":"grant","planned":false,"acquired":true,"shares":10865,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"Each restricted stock unit (\"RSU\") reflected in this row represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration, subject to continued service as described in footnote 8 below."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"25% of the award shall vest annually on the anniversary of the grant date, with the first tranche vesting on April 1, 2027, subject to the Reporting Person's continued service to the Issuer on each vesting date.  These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"25% of the award shall vest annually on the anniversary of the grant date, with the first tranche vesting on April 1, 2027, subject to the Reporting Person's continued service to the Issuer on each vesting date.  These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date."}],"balance_after":10865,"derivative":{"underlying":"Class A Common Stock","underlying_shares":10865},"source":{"system":"sec-edgar","filing":"0001944119-26-000011","document":"form4-03052026_100308.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411926000011/form4-03052026_100308.xml","form_type":"4"}},{"id":858880,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-03-05T22:49:11.000Z","date":"2026-03-04","kind":"sale","planned":false,"acquired":false,"shares":2220,"price":79.2492,"value":175933.224,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of the 2025 PRSU Award. The sales were effected to satisfy tax withholding obligations to be funded by a\n\"sell to cover\" transaction."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.00 to $79.64 per share, inclusive."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Following the reported sale undertaken to satisfy tax withholding liabilities and as of the date of filing of this Form 4, in addition to the 18,674 shares of Class A Common Stock beneficially owned by the Reporting Person, the Reporting Person beneficially owned RSUs representing contingent rights to receive up to an aggregate 122,897 shares of Class A Common Stock and options to purchase up to an aggregate 25,906 shares of Class A Common Stock, which RSUs and options vest according to their respective terms."}],"balance_after":18674,"source":{"system":"sec-edgar","filing":"0001944119-26-000011","document":"form4-03052026_100308.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411926000011/form4-03052026_100308.xml","form_type":"4"}},{"id":858879,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-03-05T22:49:11.000Z","date":"2026-03-04","kind":"sale","planned":false,"acquired":false,"shares":2543,"price":78.6069,"value":199897.3467,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of the 2025 PRSU Award. The sales were effected to satisfy tax withholding obligations to be funded by a\n\"sell to cover\" transaction."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.00 to $78.93 per share, inclusive."}],"balance_after":20894,"source":{"system":"sec-edgar","filing":"0001944119-26-000011","document":"form4-03052026_100308.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411926000011/form4-03052026_100308.xml","form_type":"4"}},{"id":858878,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-03-05T22:49:11.000Z","date":"2026-03-04","kind":"sale","planned":false,"acquired":false,"shares":1424,"price":77.6261,"value":110539.5664,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of the 2025 PRSU Award. The sales were effected to satisfy tax withholding obligations to be funded by a\n\"sell to cover\" transaction."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.00 to $77.92 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnotes 4 and 5 of this Form 4."}],"balance_after":23437,"source":{"system":"sec-edgar","filing":"0001944119-26-000011","document":"form4-03052026_100308.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411926000011/form4-03052026_100308.xml","form_type":"4"}},{"id":858877,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-03-05T22:49:11.000Z","date":"2026-03-03","kind":"grant","planned":false,"acquired":true,"shares":15262,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction represents the certification of achievement of a performance-based restricted stock unit award granted to the Reporting Person by the Issuer's compensation committee on March 15, 2025 (the \"2025 PRSU Award\"). Vesting of the 2025 PRSU Award is based on achievement of corporate performance metrics tied to revenue and adjusted net income, and subject to the Reporting Person's continued service through the certification date of achievement thereof."}],"balance_after":24861,"source":{"system":"sec-edgar","filing":"0001944119-26-000011","document":"form4-03052026_100308.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411926000011/form4-03052026_100308.xml","form_type":"4"}},{"id":868375,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock Unit","published_at":"2026-03-03T21:38:41.000Z","date":"2026-03-01","kind":"exercise","planned":false,"acquired":false,"shares":718,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"6.25% of the total award vested or vests quarterly, subject to the Reporting Person's continued service to the Issuer on each vesting date, and with the first tranche vested on December 1, 2022. These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"6.25% of the total award vested or vests quarterly, subject to the Reporting Person's continued service to the Issuer on each vesting date, and with the first tranche vested on December 1, 2022. These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date."}],"balance_after":1434,"derivative":{"underlying":"Class A Common Stock","underlying_shares":718},"source":{"system":"sec-edgar","filing":"0001944119-26-000008","document":"form4-03032026_090338.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411926000008/form4-03032026_090338.xml","form_type":"4"}},{"id":868374,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-03-03T21:38:41.000Z","date":"2026-03-02","kind":"sale","planned":false,"acquired":false,"shares":287,"price":77.5187,"value":22247.8669,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $76.99 to $77.53, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Following the reported sale undertaken to satisfy tax withholding liabilities, in addition to the 9,599 shares of Class A Common Stock beneficially owned by the Reporting Person, the Reporting Person beneficially owned RSUs representing contingent rights to receive up to an aggregate of 112,032 shares of Class A Common Stock and options to purchase up to an aggregate of 25,906 shares of Class A Common Stock, which RSUs and options vest according to their respective terms."}],"balance_after":9599,"source":{"system":"sec-edgar","filing":"0001944119-26-000008","document":"form4-03032026_090338.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411926000008/form4-03032026_090338.xml","form_type":"4"}},{"id":868373,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-03-03T21:38:41.000Z","date":"2026-03-01","kind":"exercise","planned":false,"acquired":true,"shares":718,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."}],"balance_after":9886,"source":{"system":"sec-edgar","filing":"0001944119-26-000008","document":"form4-03032026_090338.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411926000008/form4-03032026_090338.xml","form_type":"4"}},{"id":925504,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock Unit","published_at":"2026-02-02T21:33:40.000Z","date":"2026-01-29","kind":"exercise","planned":false,"acquired":false,"shares":754,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of the total award vested on each of April 29, 2023 and April 29, 2024, and an additional 6.25% of the total award vested or vests thereafter on each quarterly anniversary, subject to the Reporting Person's continued service to the Issuer on each vesting date, with the last tranche scheduled to vest on April 29, 2026.  These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"25% of the total award vested on each of April 29, 2023 and April 29, 2024, and an additional 6.25% of the total award vested or vests thereafter on each quarterly anniversary, subject to the Reporting Person's continued service to the Issuer on each vesting date, with the last tranche scheduled to vest on April 29, 2026.  These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date."}],"balance_after":754,"derivative":{"underlying":"Class A Common Stock","underlying_shares":754},"source":{"system":"sec-edgar","filing":"0001944119-26-000006","document":"form4-02022026_090237.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411926000006/form4-02022026_090237.xml","form_type":"4"}},{"id":925503,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-02-02T21:33:40.000Z","date":"2026-01-29","kind":"sale","planned":false,"acquired":false,"shares":2,"price":92.0601,"value":184.1202,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Following the reported sale undertaken to satisfy tax withholding liabilities, in addition to the 9,168 shares of Class A Common Stock beneficially owned by the Reporting Person, the Reporting Person beneficially owned RSUs representing contingent rights to receive up to an aggregate of 112,750 shares of Class A Common Stock and options to purchase up to an aggregate of 25,906 shares of Class A Common Stock, which RSUs and options vest according to their respective terms."}],"balance_after":9168,"source":{"system":"sec-edgar","filing":"0001944119-26-000006","document":"form4-02022026_090237.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411926000006/form4-02022026_090237.xml","form_type":"4"}},{"id":925502,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-02-02T21:33:40.000Z","date":"2026-01-29","kind":"sale","planned":false,"acquired":false,"shares":315,"price":94,"value":29610.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."}],"balance_after":9170,"source":{"system":"sec-edgar","filing":"0001944119-26-000006","document":"form4-02022026_090237.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411926000006/form4-02022026_090237.xml","form_type":"4"}},{"id":925501,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-02-02T21:33:40.000Z","date":"2026-01-29","kind":"exercise","planned":false,"acquired":true,"shares":754,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."}],"balance_after":9485,"source":{"system":"sec-edgar","filing":"0001944119-26-000006","document":"form4-02022026_090237.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411926000006/form4-02022026_090237.xml","form_type":"4"}},{"id":963312,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock Unit","published_at":"2025-12-18T22:20:36.000Z","date":"2025-12-16","kind":"exercise","planned":false,"acquired":false,"shares":7197,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F13","text":"6.25% of the total award vested or vests quarterly, subject to the Reporting Person's continued service to the Issuer on each vesting date, and with the first tranche vested on March 16, 2023. These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F13","text":"6.25% of the total award vested or vests quarterly, subject to the Reporting Person's continued service to the Issuer on each vesting date, and with the first tranche vested on March 16, 2023. These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date."}],"balance_after":35984,"derivative":{"underlying":"Class A Common Stock","underlying_shares":7197},"source":{"system":"sec-edgar","filing":"0001944119-25-000021","document":"form4-12182025_101232.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411925000021/form4-12182025_101232.xml","form_type":"4"}},{"id":963311,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2025-12-18T22:20:36.000Z","date":"2025-12-16","kind":"sale","planned":false,"acquired":false,"shares":127,"price":140.45,"value":17837.15,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F12","text":"Following the reported sale undertaken to satisfy tax withholding liabilities, in addition to the 8,731 shares of Class A Common Stock beneficially owned by the Reporting Person, the Reporting Person beneficially owned RSUs representing contingent rights to receive up to an aggregate of 113,504 shares of Class A Common Stock and options to purchase up to an aggregate of 25,906 shares of Class A Common Stock, which RSUs and options vest according to their respective terms."}],"balance_after":8731,"source":{"system":"sec-edgar","filing":"0001944119-25-000021","document":"form4-12182025_101232.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411925000021/form4-12182025_101232.xml","form_type":"4"}},{"id":963310,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2025-12-18T22:20:36.000Z","date":"2025-12-16","kind":"sale","planned":false,"acquired":false,"shares":26,"price":150.75,"value":3919.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."}],"balance_after":8858,"source":{"system":"sec-edgar","filing":"0001944119-25-000021","document":"form4-12182025_101232.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411925000021/form4-12182025_101232.xml","form_type":"4"}},{"id":963309,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2025-12-18T22:20:36.000Z","date":"2025-12-16","kind":"sale","planned":false,"acquired":false,"shares":97,"price":149.198,"value":14472.206,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F11","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $149.01 to $149.32, inclusive."}],"balance_after":8884,"source":{"system":"sec-edgar","filing":"0001944119-25-000021","document":"form4-12182025_101232.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411925000021/form4-12182025_101232.xml","form_type":"4"}},{"id":963308,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2025-12-18T22:20:36.000Z","date":"2025-12-16","kind":"sale","planned":false,"acquired":false,"shares":331,"price":148.5496,"value":49169.9176,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $147.85 to $148.76, inclusive."}],"balance_after":8981,"source":{"system":"sec-edgar","filing":"0001944119-25-000021","document":"form4-12182025_101232.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411925000021/form4-12182025_101232.xml","form_type":"4"}},{"id":963307,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2025-12-18T22:20:36.000Z","date":"2025-12-16","kind":"sale","planned":false,"acquired":false,"shares":699,"price":146.9282,"value":102702.8118,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $146.605 to $147.51, inclusive."}],"balance_after":9312,"source":{"system":"sec-edgar","filing":"0001944119-25-000021","document":"form4-12182025_101232.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411925000021/form4-12182025_101232.xml","form_type":"4"}},{"id":963306,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2025-12-18T22:20:36.000Z","date":"2025-12-16","kind":"sale","planned":false,"acquired":false,"shares":578,"price":145.3562,"value":84015.8836,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $144.80 to $145.55, inclusive."}],"balance_after":10011,"source":{"system":"sec-edgar","filing":"0001944119-25-000021","document":"form4-12182025_101232.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411925000021/form4-12182025_101232.xml","form_type":"4"}},{"id":963305,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2025-12-18T22:20:36.000Z","date":"2025-12-16","kind":"sale","planned":false,"acquired":false,"shares":334,"price":144.2738,"value":48187.4492,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $143.75 to $144.74, inclusive."}],"balance_after":10589,"source":{"system":"sec-edgar","filing":"0001944119-25-000021","document":"form4-12182025_101232.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411925000021/form4-12182025_101232.xml","form_type":"4"}},{"id":963304,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2025-12-18T22:20:36.000Z","date":"2025-12-16","kind":"sale","planned":false,"acquired":false,"shares":215,"price":142.1187,"value":30555.5205,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $141.76 to $142.41, inclusive."}],"balance_after":10923,"source":{"system":"sec-edgar","filing":"0001944119-25-000021","document":"form4-12182025_101232.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411925000021/form4-12182025_101232.xml","form_type":"4"}},{"id":963303,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2025-12-18T22:20:36.000Z","date":"2025-12-16","kind":"sale","planned":false,"acquired":false,"shares":951,"price":141.2047,"value":134285.6697,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $140.72 to $141.68, inclusive."}],"balance_after":11138,"source":{"system":"sec-edgar","filing":"0001944119-25-000021","document":"form4-12182025_101232.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411925000021/form4-12182025_101232.xml","form_type":"4"}},{"id":963302,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2025-12-18T22:20:36.000Z","date":"2025-12-16","kind":"sale","planned":false,"acquired":false,"shares":366,"price":140.0824,"value":51270.1584,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $139.70 to $140.465, inclusive."}],"balance_after":12089,"source":{"system":"sec-edgar","filing":"0001944119-25-000021","document":"form4-12182025_101232.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411925000021/form4-12182025_101232.xml","form_type":"4"}},{"id":963301,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2025-12-18T22:20:36.000Z","date":"2025-12-16","kind":"sale","planned":false,"acquired":false,"shares":131,"price":138.93,"value":18199.83,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $138.65 to $139.41, inclusive.  The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnotes 4 through 11."}],"balance_after":12455,"source":{"system":"sec-edgar","filing":"0001944119-25-000021","document":"form4-12182025_101232.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411925000021/form4-12182025_101232.xml","form_type":"4"}},{"id":963300,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2025-12-18T22:20:36.000Z","date":"2025-12-16","kind":"exercise","planned":false,"acquired":true,"shares":7197,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."}],"balance_after":12586,"source":{"system":"sec-edgar","filing":"0001944119-25-000021","document":"form4-12182025_101232.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411925000021/form4-12182025_101232.xml","form_type":"4"}},{"id":972801,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock Unit","published_at":"2025-12-11T21:31:09.000Z","date":"2025-12-09","kind":"exercise","planned":false,"acquired":false,"shares":2462,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"6.25% of the total award vested or vests quarterly, subject to the Reporting Person's continued service to the Issuer on each vesting date, and with the first tranche vested on March 9, 2023. These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"6.25% of the total award vested or vests quarterly, subject to the Reporting Person's continued service to the Issuer on each vesting date, and with the first tranche vested on March 9, 2023. These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date."}],"balance_after":9849,"derivative":{"underlying":"Class A Common Stock","underlying_shares":2462},"source":{"system":"sec-edgar","filing":"0001944119-25-000020","document":"form4-12112025_091200.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411925000020/form4-12112025_091200.xml","form_type":"4"}},{"id":972800,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2025-12-11T21:31:09.000Z","date":"2025-12-09","kind":"sale","planned":false,"acquired":false,"shares":1266,"price":159.28,"value":201648.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Following the reported sale undertaken to satisfy tax withholding liabilities, in addition to the 5,389 shares of Class A Common Stock beneficially owned by the Reporting Person, the Reporting Person beneficially owned RSUs representing contingent rights to receive up to an aggregate of 120,701 shares of Class A Common Stock and options to purchase up to an aggregate of 25,906 shares of Class A Common Stock, which RSUs and options vest according to their respective terms."}],"balance_after":5389,"source":{"system":"sec-edgar","filing":"0001944119-25-000020","document":"form4-12112025_091200.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411925000020/form4-12112025_091200.xml","form_type":"4"}},{"id":972799,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2025-12-11T21:31:09.000Z","date":"2025-12-09","kind":"exercise","planned":false,"acquired":true,"shares":2462,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."}],"balance_after":6655,"source":{"system":"sec-edgar","filing":"0001944119-25-000020","document":"form4-12112025_091200.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411925000020/form4-12112025_091200.xml","form_type":"4"}},{"id":981836,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock Unit","published_at":"2025-12-03T21:18:51.000Z","date":"2025-12-01","kind":"exercise","planned":false,"acquired":false,"shares":717,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"6.25% of the total award vested or vests quarterly, subject to the Reporting Person's continued service to the Issuer on each vesting date, and with the first tranche vested on December 1, 2022.  These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"6.25% of the total award vested or vests quarterly, subject to the Reporting Person's continued service to the Issuer on each vesting date, and with the first tranche vested on December 1, 2022.  These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date."}],"balance_after":2152,"derivative":{"underlying":"Class A Common Stock","underlying_shares":717},"source":{"system":"sec-edgar","filing":"0001944119-25-000018","document":"form4-12032025_091247.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411925000018/form4-12032025_091247.xml","form_type":"4"}},{"id":981835,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2025-12-03T21:18:51.000Z","date":"2025-12-01","kind":"sale","planned":false,"acquired":false,"shares":377,"price":162.536,"value":61276.072,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $162.3501 to $162.5400, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Following the reported sale undertaken to satisfy tax withholding liabilities, in addition to the 4,193 shares of Class A Common Stock beneficially owned by the Reporting Person, the Reporting Person beneficially owned RSUs representing contingent rights to receive up to an aggregate of 123,163 shares of Class A Common Stock and options to purchase up to an aggregate of 25,906 shares of Class A Common Stock, which RSUs and options vest according to their respective terms."}],"balance_after":4193,"source":{"system":"sec-edgar","filing":"0001944119-25-000018","document":"form4-12032025_091247.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411925000018/form4-12032025_091247.xml","form_type":"4"}},{"id":981834,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2025-12-03T21:18:51.000Z","date":"2025-12-01","kind":"exercise","planned":false,"acquired":true,"shares":717,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The reported total includes 96 shares of the Issuer's Class A Common Stock acquired by the reporting person in one or more transactions with the Issuer pursuant to its Employee Stock Purchase Plan, which transactions are exempt pursuant to Rules 16a3(f)(1)(i)(B) and 16b3(c)."}],"balance_after":4570,"source":{"system":"sec-edgar","filing":"0001944119-25-000018","document":"form4-12032025_091247.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411925000018/form4-12032025_091247.xml","form_type":"4"}},{"id":1010788,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock Unit","published_at":"2025-10-31T20:41:26.000Z","date":"2025-10-29","kind":"exercise","planned":false,"acquired":false,"shares":753,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of the total award vested on each of April 29, 2023 and April 29, 2024, and an additional 6.25% of the total award vested or vests thereafter on each quarterly anniversary, subject to the Reporting Person's continued service to the Issuer on each vesting date, with the last tranche scheduled to vest on April 29, 2026.  These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"25% of the total award vested on each of April 29, 2023 and April 29, 2024, and an additional 6.25% of the total award vested or vests thereafter on each quarterly anniversary, subject to the Reporting Person's continued service to the Issuer on each vesting date, with the last tranche scheduled to vest on April 29, 2026.  These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date."}],"balance_after":1508,"derivative":{"underlying":"Class A Common Stock","underlying_shares":753},"source":{"system":"sec-edgar","filing":"0001944119-25-000015","document":"form4-10312025_081022.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411925000015/form4-10312025_081022.xml","form_type":"4"}},{"id":1010787,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2025-10-31T20:41:26.000Z","date":"2025-10-29","kind":"sale","planned":false,"acquired":false,"shares":388,"price":136.54,"value":52977.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Following the reported sale undertaken to satisfy tax withholding liabilities, in addition to the 3,757 shares of Class A Common Stock beneficially owned by the Reporting Person, the Reporting Person beneficially owned RSUs representing contingent rights to receive up to an aggregate of 123,880 shares of Class A Common Stock and options to purchase up to an aggregate of 25,906 shares of Class A Common Stock, which RSUs and options vest according to their respective terms."}],"balance_after":3757,"source":{"system":"sec-edgar","filing":"0001944119-25-000015","document":"form4-10312025_081022.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411925000015/form4-10312025_081022.xml","form_type":"4"}},{"id":1010786,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2025-10-31T20:41:26.000Z","date":"2025-10-29","kind":"exercise","planned":false,"acquired":true,"shares":753,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."}],"balance_after":4145,"source":{"system":"sec-edgar","filing":"0001944119-25-000015","document":"form4-10312025_081022.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411925000015/form4-10312025_081022.xml","form_type":"4"}},{"id":1029541,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-10-01T20:18:24.000Z","date":"2025-09-30","kind":"exercise","planned":true,"acquired":false,"shares":1246,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 21, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The award vested or vests as to 6.25% of the total award quarterly over the 4-year period commencing on December 1, 2022 until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date."}],"balance_after":4982,"derivative":{"exercise_price":32.67,"expiration_date":"2032-08-31","underlying":"Class A Common Stock","underlying_shares":1246},"source":{"system":"sec-edgar","filing":"0001944119-25-000012","document":"form4-10012025_081020.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411925000012/form4-10012025_081020.xml","form_type":"4"}},{"id":1029540,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2025-10-01T20:18:24.000Z","date":"2025-09-30","kind":"sale","planned":true,"acquired":false,"shares":70,"price":113.68,"value":7957.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 21, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F8","text":"Following the reported sales effectuated pursuant to a 10b5-1 plan, in addition to the 3,392 shares of Class A common stock beneficially owned by the Reporting Person, the Reporting Person beneficially owned restricted stock units (\"RSUs\") representing contingent rights to receive up to an aggregate of 124,633 shares of Class A common stock and options to purchase up to an aggregate of 25,906 shares of Class A common stock, which RSUs and options vest according to their respective terms."}],"balance_after":3392,"source":{"system":"sec-edgar","filing":"0001944119-25-000012","document":"form4-10012025_081020.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411925000012/form4-10012025_081020.xml","form_type":"4"}},{"id":1029539,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2025-10-01T20:18:24.000Z","date":"2025-09-30","kind":"sale","planned":true,"acquired":false,"shares":520,"price":111.9312,"value":58204.224,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 21, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $111.50 to $112.04, inclusive."}],"balance_after":3462,"source":{"system":"sec-edgar","filing":"0001944119-25-000012","document":"form4-10012025_081020.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411925000012/form4-10012025_081020.xml","form_type":"4"}},{"id":1029538,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2025-10-01T20:18:24.000Z","date":"2025-09-30","kind":"sale","planned":true,"acquired":false,"shares":421,"price":110.0474,"value":46329.9554,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 21, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $109.3225 to $110.25, inclusive."}],"balance_after":3982,"source":{"system":"sec-edgar","filing":"0001944119-25-000012","document":"form4-10012025_081020.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411925000012/form4-10012025_081020.xml","form_type":"4"}},{"id":1029537,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2025-10-01T20:18:24.000Z","date":"2025-09-30","kind":"sale","planned":true,"acquired":false,"shares":2152,"price":108.667,"value":233851.384,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 21, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $108.23 to $109.1754, inclusive."}],"balance_after":4403,"source":{"system":"sec-edgar","filing":"0001944119-25-000012","document":"form4-10012025_081020.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411925000012/form4-10012025_081020.xml","form_type":"4"}},{"id":1029536,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2025-10-01T20:18:24.000Z","date":"2025-09-30","kind":"sale","planned":true,"acquired":false,"shares":2715,"price":107.6835,"value":292360.7025,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 21, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.22 to $108.20, inclusive."}],"balance_after":6555,"source":{"system":"sec-edgar","filing":"0001944119-25-000012","document":"form4-10012025_081020.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411925000012/form4-10012025_081020.xml","form_type":"4"}},{"id":1029535,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2025-10-01T20:18:24.000Z","date":"2025-09-30","kind":"sale","planned":true,"acquired":false,"shares":387,"price":106.8574,"value":41353.8138,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 21, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.1354 to $107.01, inclusive."}],"balance_after":9270,"source":{"system":"sec-edgar","filing":"0001944119-25-000012","document":"form4-10012025_081020.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411925000012/form4-10012025_081020.xml","form_type":"4"}},{"id":1029534,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2025-10-01T20:18:24.000Z","date":"2025-09-30","kind":"sale","planned":true,"acquired":false,"shares":344,"price":105.2412,"value":36202.9728,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 21, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $104.98 to $105.91, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnotes 3 through 7."}],"balance_after":9657,"source":{"system":"sec-edgar","filing":"0001944119-25-000012","document":"form4-10012025_081020.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411925000012/form4-10012025_081020.xml","form_type":"4"}},{"id":1029533,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2025-10-01T20:18:24.000Z","date":"2025-09-30","kind":"exercise","planned":true,"acquired":true,"shares":1246,"price":32.67,"value":40706.82,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 21, 2024."}],"balance_after":10001,"source":{"system":"sec-edgar","filing":"0001944119-25-000012","document":"form4-10012025_081020.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411925000012/form4-10012025_081020.xml","form_type":"4"}},{"id":1036447,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2025-09-19T01:50:47.000Z","date":"2025-09-16","kind":"exercise","planned":false,"acquired":true,"shares":7197,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."}],"balance_after":12483,"source":{"system":"sec-edgar","filing":"0001944119-25-000005","document":"form4a-09192025_010943.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411925000005/form4a-09192025_010943.xml","form_type":"4/A","original_submission_date":"2025-09-18"}},{"id":1036446,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock Unit","published_at":"2025-09-18T22:05:29.000Z","date":"2025-09-16","kind":"exercise","planned":false,"acquired":false,"shares":7197,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"6.25% vest in quarterly installments over the 4-year period commencing on March 16, 2023 until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"6.25% vest in quarterly installments over the 4-year period commencing on March 16, 2023 until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date."}],"balance_after":43181,"derivative":{"underlying":"Class A Common Stock","underlying_shares":7197},"source":{"system":"sec-edgar","filing":"0001944119-25-000003","document":"form4-09182025_100926.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411925000003/form4-09182025_100926.xml","form_type":"4"}},{"id":1036445,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2025-09-18T22:05:29.000Z","date":"2025-09-16","kind":"sale","planned":false,"acquired":false,"shares":3728,"price":121.4727,"value":452850.2256,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. These shares were sold as part of a block trade for multiple security holders of the Issuer in multiple transactions at prices ranging from $118.28 to $123.07, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 3 with regard to the block trade."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Following the reported sales, in addition to the 8,755 shares of Class A common stock beneficially owned by the Reporting Person, the Reporting Person beneficially owned restricted stock units (\"RSUs\") representing contingent rights to receive up to an aggregate of 124,633 shares of Class A common stock and options to purchase up to an aggregate of 27,152 shares of Class A common stock, which RSUs and options vest according to their respective terms."}],"balance_after":8755,"source":{"system":"sec-edgar","filing":"0001944119-25-000003","document":"form4-09182025_100926.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411925000003/form4-09182025_100926.xml","form_type":"4"}},{"id":1036444,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2025-09-18T22:05:29.000Z","date":"2025-09-16","kind":"exercise","planned":false,"acquired":false,"shares":7197,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."}],"balance_after":12483,"source":{"system":"sec-edgar","filing":"0001944119-25-000003","document":"form4-09182025_100926.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411925000003/form4-09182025_100926.xml","form_type":"4"}},{"id":1043016,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock Unit","published_at":"2025-09-11T20:06:30.000Z","date":"2025-09-09","kind":"exercise","planned":false,"acquired":false,"shares":2462,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"6.25% vest in quarterly installments over the 4-year period commencing on March 9, 2023 until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"6.25% vest in quarterly installments over the 4-year period commencing on March 9, 2023 until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date."}],"balance_after":12311,"derivative":{"underlying":"Class A Common Stock","underlying_shares":2462},"source":{"system":"sec-edgar","filing":"0001415889-25-024270","document":"form4-09112025_080926.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000141588925024270/form4-09112025_080926.xml","form_type":"4"}},{"id":1043015,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2025-09-11T20:06:30.000Z","date":"2025-09-09","kind":"sale","planned":false,"acquired":false,"shares":6,"price":129.09,"value":774.54,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sales were to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Following the reported sales, in addition to the 5,286 shares of Class A common stock beneficially owned by the Reporting Person, the Reporting Person beneficially owned restricted stock units (\"RSUs\") representing contingent rights to receive up to an aggregate of 131,830 shares of Class A common stock and options to purchase up to an aggregate of 27,152 shares of Class A common stock, which RSUs and options vest according to their respective terms."}],"balance_after":5286,"source":{"system":"sec-edgar","filing":"0001415889-25-024270","document":"form4-09112025_080926.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000141588925024270/form4-09112025_080926.xml","form_type":"4"}},{"id":1043014,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2025-09-11T20:06:30.000Z","date":"2025-09-09","kind":"sale","planned":false,"acquired":false,"shares":1266,"price":128.05,"value":162111.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sales were to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."}],"balance_after":5292,"source":{"system":"sec-edgar","filing":"0001415889-25-024270","document":"form4-09112025_080926.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000141588925024270/form4-09112025_080926.xml","form_type":"4"}},{"id":1043013,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2025-09-11T20:06:30.000Z","date":"2025-09-09","kind":"exercise","planned":false,"acquired":true,"shares":2462,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."}],"balance_after":6558,"source":{"system":"sec-edgar","filing":"0001415889-25-024270","document":"form4-09112025_080926.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000141588925024270/form4-09112025_080926.xml","form_type":"4"}},{"id":1050018,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock Unit","published_at":"2025-09-03T22:31:59.000Z","date":"2025-09-01","kind":"exercise","planned":false,"acquired":false,"shares":717,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"6.25% vest in quarterly installments over the 4-year period commencing on December 1, 2022 until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"6.25% vest in quarterly installments over the 4-year period commencing on December 1, 2022 until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date."}],"balance_after":2869,"derivative":{"underlying":"Class A Common Stock","underlying_shares":717},"source":{"system":"sec-edgar","filing":"0001415889-25-023601","document":"form4-09032025_100956.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000141588925023601/form4-09032025_100956.xml","form_type":"4"}},{"id":1050017,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2025-09-03T22:31:59.000Z","date":"2025-09-02","kind":"sale","planned":false,"acquired":false,"shares":378,"price":125.8096,"value":47556.0288,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sales were to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $125.80 to $126.2050 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Following the reported sales, in addition to the 4,096 shares of Class A common stock beneficially owned by the Reporting Person, the Reporting Person beneficially owned restricted stock units (\"RSUs\") representing contingent rights to receive up to an aggregate of 134,292 shares of Class A common stock and options to purchase up to an aggregate of 27,152 shares of Class A common stock, which RSUs and options vest according to their respective terms."}],"balance_after":4096,"source":{"system":"sec-edgar","filing":"0001415889-25-023601","document":"form4-09032025_100956.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000141588925023601/form4-09032025_100956.xml","form_type":"4"}},{"id":1050016,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2025-09-03T22:31:59.000Z","date":"2025-09-01","kind":"exercise","planned":false,"acquired":true,"shares":717,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."}],"balance_after":4474,"source":{"system":"sec-edgar","filing":"0001415889-25-023601","document":"form4-09032025_100956.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000141588925023601/form4-09032025_100956.xml","form_type":"4"}},{"id":1078487,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock Unit","published_at":"2025-07-31T20:06:11.000Z","date":"2025-07-29","kind":"exercise","planned":false,"acquired":false,"shares":753,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of the total RSUs vest on April 29, 2023 and April 29, 2024, and thereafter 6.25% of the total shares underlying the award shall vest in equal quarterly installments until fully vested on April 29, 2026, subject to the Reporting Person's continued service to the Issuer on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"25% of the total RSUs vest on April 29, 2023 and April 29, 2024, and thereafter 6.25% of the total shares underlying the award shall vest in equal quarterly installments until fully vested on April 29, 2026, subject to the Reporting Person's continued service to the Issuer on each vesting date."}],"balance_after":2261,"derivative":{"underlying":"Class A Common Stock","underlying_shares":753},"source":{"system":"sec-edgar","filing":"0001415889-25-020715","document":"form4-07312025_080706.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000141588925020715/form4-07312025_080706.xml","form_type":"4"}}],"next_cursor":"2025-07-31T20:06:11.000000Z,1078487"}